Cargando…

Cardiac Insulin Resistance and MicroRNA Modulators

Cardiac insulin resistance is a metabolic and functional disorder that is often associated with obesity and/or the cardiorenal metabolic syndrome (CRS), and this disorder may be accentuated by chronic alcohol consumption. In conditions of over-nutrition, increased insulin (INS) and angiotensin II (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulakat, Lakshmi, Aroor, Annayya R., Gul, Rukhsana, Sowers, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184440/ https://www.ncbi.nlm.nih.gov/pubmed/21977024 http://dx.doi.org/10.1155/2012/654904

Ejemplares similares

Regulation of Cardiac Expression of the Diabetic Marker MicroRNA miR-29
por: Arnold, Nicholas, et al.
Publicado: (2014)

Vascular stiffness in insulin resistance and obesity
por: Jia, Guanghong, et al.
Publicado: (2015)

Glucagon-Like Peptide 1 Receptor Activation and Platelet Function: Beyond Glycemic Control
por: Jia, Guanghong, et al.
Publicado: (2016)

Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy
por: Pulakat, Lakshmi, et al.
Publicado: (2020)

Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature
por: Belenchia, Anthony M., et al.
Publicado: (2018)

Dipeptidyl Peptidase-4 Inhibition Ameliorates Western Diet–Induced Hepatic Steatosis and Insulin Resistance Through Hepatic Lipid Remodeling and Modulation of Hepatic Mitochondrial Function
por: Aroor, Annayya R., et al.
Publicado: (2015)

Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol
por: Gul, Rukhsana, et al.
Publicado: (2015)

Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules
por: Aroor, Annayya, et al.
Publicado: (2016)

Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA
por: Sidorkiewicz, Iwona, et al.
Publicado: (2020)

The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness
por: Aroor, Annayya R., et al.
Publicado: (2013)

The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
por: Aroor, Annayya R., et al.
Publicado: (2018)

MicroRNA, Insulin Resistance, and Metabolic Disorders
por: Lee, Wan
Publicado: (2022)

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
por: Habibi, Javad, et al.
Publicado: (2017)

MicroRNAs in Insulin Resistance and Obesity
por: Williams, Michael D., et al.
Publicado: (2012)

SAT-LB011 Role of Endothelium Epithelial Sodium Channel in Arterial Stiffness
por: Jia, Guanghong, et al.
Publicado: (2019)

SAT-LB97 MiRNA-99a and mTOR2 Mediate Enhanced Endothelial Mineralocorticoid Receptor Signaling-Induced Activation of Sodium Channel and Endothelium Stiffness
por: Jia, Guanghong, et al.
Publicado: (2020)

MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
por: Costa, Pedro M., et al.
Publicado: (2013)

Biomarkers of obesity-mediated insulin resistance: focus on microRNAs
por: Cai, Yichen, et al.
Publicado: (2023)

Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction
por: Igbekele, Aderonke E., et al.
Publicado: (2022)

Modulators of MicroRNA Function in the Immune System
por: Jia, Yunhui, et al.
Publicado: (2020)

MicroRNA Modulation by Dietary Supplements in Obesity
por: Filardi, Tiziana, et al.
Publicado: (2020)

MicroRNA-1 in Cardiac Diseases and Cancers
por: Li, Jianzhe, et al.
Publicado: (2014)

Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases
por: Climent, Montserrat, et al.
Publicado: (2020)

Modulation of microRNA Activity by Semi-microRNAs
por: Plante, Isabelle, et al.
Publicado: (2012)

MicroRNA-mediated drug resistance in breast cancer
por: Kutanzi, Kristy R., et al.
Publicado: (2011)

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the Zucker obese rat
por: Nistala, Ravi, et al.
Publicado: (2014)

RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders: Status and Challenges
por: Poller, W., et al.
Publicado: (2008)

MicroRNA Networks Modulate Oxidative Stress in Cancer
por: Lin, Yang-Hsiang
Publicado: (2019)

microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
por: Langlet, Fanny, et al.
Publicado: (2018)

MicroRNA as a Therapeutic Target in Cardiac Remodeling
por: Chen, Chao, et al.
Publicado: (2017)

microRNA and thyroid hormone signaling in cardiac and skeletal muscle
por: Zhang, Duo, et al.
Publicado: (2017)

MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue
por: Chuang, Tung-Yueh, et al.
Publicado: (2015)

Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance
por: Song, Yuping, et al.
Publicado: (2019)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

The MicroRNA (miRNA): Overview of the RNA Genes that Modulate Gene Function
por: Ying, Shao-Yao, et al.
Publicado: (2007)

Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet
por: Martinez-Lemus, Luis A., et al.
Publicado: (2017)

MicroRNA Targeting to Modulate Tumor Microenvironment
por: Kuninty, Praneeth R., et al.
Publicado: (2016)

MicroRNAs in Cardiac Diseases
por: Colpaert, Robin M.W., et al.
Publicado: (2019)

MicroRNAs in Cardiac Hypertrophy
por: Wehbe, Nadine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bofvpjoh1iliaumid846p5qflr